139 related articles for article (PubMed ID: 38600694)
1. The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial.
Kalyvianakis D; Mykoniatis I; Pyrgidis N; Kapoteli P; Zilotis F; Hatzichristou D
J Sex Med; 2024 May; 21(6):533-538. PubMed ID: 38600694
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
Mykoniatis I; Pyrgidis N; Zilotis F; Kapoteli P; Fournaraki A; Kalyvianakis D; Hatzichristou D
J Sex Med; 2022 Jan; 19(1):106-115. PubMed ID: 34866029
[TBL] [Abstract][Full Text] [Related]
3. Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.
Kalyvianakis D; Hatzichristou D
J Sex Med; 2017 Jul; 14(7):891-897. PubMed ID: 28673433
[TBL] [Abstract][Full Text] [Related]
4. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
[TBL] [Abstract][Full Text] [Related]
5. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment.
Kalyvianakis D; Memmos E; Mykoniatis I; Kapoteli P; Memmos D; Hatzichristou D
J Sex Med; 2018 Mar; 15(3):334-345. PubMed ID: 29396020
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
[TBL] [Abstract][Full Text] [Related]
7. The impact of extracorporeal shock wave therapy for the treatment of young patients with vasculogenic mild erectile dysfunction: A prospective randomized single-blind, sham controlled study.
Ortac M; Özmez A; Cilesiz NC; Demirelli E; Kadıoğlu A
Andrology; 2021 Sep; 9(5):1571-1578. PubMed ID: 33780173
[TBL] [Abstract][Full Text] [Related]
8. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.
Baccaglini W; Pazeto CL; Corrêa Barros EA; Timóteo F; Monteiro L; Saad Rached RY; Navas A; Glina S
J Sex Med; 2020 Apr; 17(4):688-694. PubMed ID: 32007430
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up.
Gallo L; Pecoraro S; Sarnacchiaro P
Investig Clin Urol; 2022 Jan; 63(1):83-91. PubMed ID: 34983126
[TBL] [Abstract][Full Text] [Related]
11. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.
Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D
JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
[TBL] [Abstract][Full Text] [Related]
14. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
[TBL] [Abstract][Full Text] [Related]
15. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population.
Srini VS; Reddy RK; Shultz T; Denes B
Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008
[TBL] [Abstract][Full Text] [Related]
16. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
[TBL] [Abstract][Full Text] [Related]
17. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
[TBL] [Abstract][Full Text] [Related]
20. Role of Serum High-Sensitivity C-Reactive Protein as a Predictor of Therapeutic Response to Tadalafil in Patients With Erectile Dysfunction: A Prospective Observational Study.
Jamaluddin ; Bansal M; Srivastava GK; Gupta NP
J Sex Med; 2019 Dec; 16(12):1912-1921. PubMed ID: 31668733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
